Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming
This review reframes diabetes as an active metabolic determinant of PC rather than a coincidental comorbidity and highlights metabolism-centered precision strategies as promising avenues for improving risk stratification, therapeutic decision-making, and clinical outcomes in diabetes-associated PC.